This study aimed to validate, in a cohort of non-diabetic patients with no previous liver diseases, the correlation between ALT APRI scores and obesity and the role of elevated APRI as a marker of severe obesity-related metabolic disturbances. This evidence concerns the gene GPT and obesity disorder.